在化疗后,SHIPi改善了血液的恢复
Sandra Fernandes1, Chiara Pedicone1, Otto M Dungan2
1Department of Microbiology & Immunology, SUNY Upstate Medical University, Syracuse, NY, USA.
Molecular medicine (Cambridge, Mass.)
|October 22, 2025
概括
SHIP1的小分子抑制剂 (体质增生抑制剂1) 可以促进身体自然产生生长因子,改善化疗后的恢复,增加生存率.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 再组合生长因子改善化疗后的造血功能,但危及生命的血液和免疫并发症仍然存在.
- 现有的治疗方法在完全缓解化疗引起的并发症方面面临挑战.
研究的目的:
- 调查泛SHIP抑制剂 (泛SHIPi) 和新型SHIP1选择性抑制剂的潜力,以增强内源生长因子的产生和改善化疗后的结果.
- 评估这些抑制剂在促进血液恢复和增加宿主存活率方面的有效性.
主要方法:
- 将泛SHIPi化合物和一种新的SHIP1选择性抑制剂 (A32) 给小鼠.
- 在体内评估内源性G-CSF (颗粒细胞殖民地刺激因子) 和TPO (血小板蛋白) 生产.
- 在致命的真菌挑战后对宿主生存的评估.
- 化疗后颗粒形成和中性粒细胞数恢复的分析.
主要成果:
- 全SHIPi化合物诱导了内源G-CSF和TPO的产生,增加了致命的真菌挑战后宿主生存率.
- 全SHIPi化合物促进了小鼠化疗后的颗粒形成和加速中性粒细胞数的恢复.
- 新型SHIP1选择性抑制剂A32也增加了稳定状态G-CSF和TPO的产生.
结论:
- SHIP1的小分子抑制剂有效地促进骨髓缩化疗后的血液恢复.
- SHIP1抑制剂代表了一种新的策略,用于诱导内源性产生多种生长因子,这对血液恢复至关重要.
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Bone Marrow Sampling and Transplants
876
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
876
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Hematopoiesis
8.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.7K
Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


